Automating Vascular Biology: An End‐to‐End Automated Workflow for High‐Throughput Blood Vessel‐on‐a‐Chip Production and Multi‐Site Validation
Advanced Healthcare Materials · 2026-03 · 15 (12)
DOI: 10.1002/adhm.202504933 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 08.01.2026. Verfasst von Dawn S Y Lin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Lab-On-A-Chip Devices, Blood Vessels. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
There is a growing demand for automated organ‐on‐a‐chip platforms that are compatible with off‐the‐shelf robotic liquid‐handling systems and plate readers to improve reproducibility and scalable analysis. In this work, we present an end‐to‐end automated method for fabricating tubular blood vessel models at scale using a custom 384‐well open‐top platform (AngioPlate384), designed to support integration with liquid‐handling systems and large‐scale analysis. Our approach enables the generation of over 100 perfusable blood vessels fully embedded in hydrogel and supported by stromal cells (fibroblasts and pericytes), allowing both luminal and interstitial flow. Using this platform, we demonstrated that stromal co‐culture significantly enhances vascular barrier function, and results in an altered response to chemotherapeutics and to inflammatory stressors. This platform offers a robust and scalable approach to generating customizable blood vessel‐on‐a‐chip models for vascular biology studies, disease modeling, and preclinical testing. Its compatibility with automation and standardized workflows positions it as a powerful tool to accelerate the adoption of microphysiological systems in pharmaceutical research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada.
- Merck & Co., Inc., Rahway, New Jersey, USA.
- School of Biomedical Engineering, McMaster University, Hamilton, Ontario, Canada.
ORCID-Profile: Dawn S Y Lin, Boyang Zhang
Förderung
- Natural Sciences and Engineering Research Council of Canada
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Lin, D. S. Y., Mohammad Hashemi, H., Asadi Jozani, K., Chakravarty, A., Kouthouridis, S., Bonanno, J., Anvari, N., Rajasekar, S., Zhang, F., Cheng, R. Y., Singh, N. K., Medina, L. M., Durante, M., He, Y., & Zhang, B. (2026). Automating Vascular Biology: An End‐to‐End Automated Workflow for High‐Throughput Blood Vessel‐on‐a‐Chip Production and Multi‐Site Validation. Advanced Healthcare Materials, 15(12). https://doi.org/10.1002/adhm.202504933
Vancouver
Lin DSY, Mohammad Hashemi H, Asadi Jozani K, Chakravarty A, Kouthouridis S, Bonanno J, et al. Automating Vascular Biology: An End‐to‐End Automated Workflow for High‐Throughput Blood Vessel‐on‐a‐Chip Production and Multi‐Site Validation. Advanced Healthcare Materials. 2026;15(12). doi:10.1002/adhm.202504933
BibTeX
@article{Lin2026,
author = {Lin, Dawn S Y and Mohammad Hashemi, Hanieh and Asadi Jozani, Kimia and Chakravarty, Anushree and Kouthouridis, Sonya and Bonanno, Jessica and Anvari, Nicky and Rajasekar, Shravanthi and Zhang, Feng and Cheng, Richard Y and Singh, Narendra Kumar and Medina, Luis Miguel and Durante, Marc and He, Yufang and Zhang, Boyang},
title = {Automating Vascular Biology: An End‐to‐End Automated Workflow for High‐Throughput Blood Vessel‐on‐a‐Chip Production and Multi‐Site Validation},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {12},
doi = {10.1002/adhm.202504933}
}
EUVIMED